Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Meningococcal group B vaccine
ID: S900006770

Note

  • FDA: Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.
 

Classification Code

  • Treatment for: Meningococcal Meningitis Prophylaxis
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Meningococcal group B vaccine

Synonyms

  • Bexsero
  • Meningococcal group B vaccines
  • Trumenba

Registry Number

  • S900006770